Search Results - "Scott, Peter JH"

Highlight selection of radiochemistry and radiopharmacy developments by editorial board by Scott, Peter JH, Penuelas, Ivan, Rey, Ana, Aime, Silvio, Ambikalmajan, Pillai M.R., Antunes, Ines Farinha, Cleeren, Frederik, Liu, Zhaofei, Ellis, Beverley, Kahts, Maryke, Ekoume, Fany Pricile, Chaple, Ivis F., Bernardes, Emerson, Behe, Martin, Huang, Ya-Yao, Mikolajczak, Renata, Furumoto, Shozo, Elrefaei, Amal, Kopka, Klaus

“…Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field…”
Get full text

Nuclear Medicine and Artificial Intelligence: Best Practices for Algorithm Development by Bradshaw, Tyler J, Boellaard, Ronald, Dutta, Joyita, Jha, Abhinav K, Jacobs, Paul, Li, Quanzheng, Liu, Chi, Sitek, Arkadiusz, Saboury, Babak, Scott, Peter J H, Slomka, Piotr J, Sunderland, John J, Wahl, Richard L, Yousefirizi, Fereshteh, Zuehlsdorff, Sven, Rahmim, Arman, Buvat, Irène

“…The nuclear medicine field has seen a rapid expansion of academic and commercial interest in developing artificial intelligence (AI) algorithms. Users and…”
Get full text

Gait speed in Parkinson disease correlates with cholinergic degeneration by Bohnen, Nicolaas I, Frey, Kirk A, Studenski, Stephanie, Kotagal, Vikas, Koeppe, Robert A, Scott, Peter J.H, Albin, Roger L, Müller, Martijn L.T.M

“…OBJECTIVE:We investigated dopaminergic and cholinergic correlates of gait speed in Parkinson disease (PD) and non-PD control subjects to test the hypothesis…”
Get full text

Ethical Considerations for Artificial Intelligence in Medical Imaging: Data Collection, Development, and Evaluation by Herington, Jonathan, McCradden, Melissa D, Creel, Kathleen, Boellaard, Ronald, Jones, Elizabeth C, Jha, Abhinav K, Rahmim, Arman, Scott, Peter J H, Sunderland, John J, Wahl, Richard L, Zuehlsdorff, Sven, Saboury, Babak

“…The development of artificial intelligence (AI) within nuclear imaging involves several ethically fraught components at different stages of the machine…”
Get full text

Ethical Considerations for Artificial Intelligence in Medical Imaging: Deployment and Governance by Herington, Jonathan, McCradden, Melissa D, Creel, Kathleen, Boellaard, Ronald, Jones, Elizabeth C, Jha, Abhinav K, Rahmim, Arman, Scott, Peter J H, Sunderland, John J, Wahl, Richard L, Zuehlsdorff, Sven, Saboury, Babak

“…The deployment of artificial intelligence (AI) has the potential to make nuclear medicine and medical imaging faster, cheaper, and both more effective and more…”
Get full text

Artificial Intelligence in Nuclear Medicine: Opportunities, Challenges, and Responsibilities Toward a Trustworthy Ecosystem by Saboury, Babak, Bradshaw, Tyler, Boellaard, Ronald, Buvat, Irène, Dutta, Joyita, Hatt, Mathieu, Jha, Abhinav K, Li, Quanzheng, Liu, Chi, McMeekin, Helena, Morris, Michael A, Scott, Peter J H, Siegel, Eliot, Sunderland, John J, Pandit-Taskar, Neeta, Wahl, Richard L, Zuehlsdorff, Sven, Rahmim, Arman

“…Trustworthiness is a core tenet of medicine. The patient-physician relationship is evolving from a dyad to a broader ecosystem of health care. With the…”
Get full text

Proceedings: PET Drugs-A Workshop on Inspections Management and Regulatory Considerations by Bunning, Sue, Ignace, Christopher, Mattmuller, Steve, Schwarz, Sally W, Scott, Peter J H, VanBrocklin, Henry F, Zigler, Steven S

“…Recent advances in the development of new molecular imaging agents for PET have led to the approval of several new molecular entities for PET imaging by the…”
Get full text

Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects by Bohnen, Nicolaas I, Albin, Roger L, Müller, Martijn L T M, Petrou, Myria, Kotagal, Vikas, Koeppe, Robert A, Scott, Peter J H, Frey, Kirk A

“…Little is known about the relative contributions of multisystem degenerative processes across the spectrum of predemented cognitive decline in Parkinson…”
Get more information

On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion by Herth, Matthias M., Ametamey, Simon, Antuganov, Dmitrii, Bauman, Andreas, Berndt, Mathias, Brooks, Allen F., Bormans, Guy, Choe, Yearn Seong, Gillings, Nic, Häfeli, Urs O., James, Michelle L., Kopka, Klaus, Kramer, Vasko, Krasikova, Raisa, Madsen, Jacob, Mu, Linjing, Neumaier, Bernd, Piel, Markus, Rösch, Frank, Ross, Tobias, Schibli, Roger, Scott, Peter J.H., Shalgunov, Vladimir, Vasdev, Neil, Wadsak, Wolfgang, Zeglis, Brian M.

“…Radiochemical conversion is an important term to be included in the “Consensus nomenclature rules for radiopharmaceutical chemistry”. Radiochemical conversion…”
Get full text

Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET by Brooks, Allen F, Winton, Wade P, Stauff, Jenelle, Arteaga, Janna, Henderson, Bradford, Niedbala, Jeremy, Scott, Peter J H, Viglianti, Benjamin L

“…Imaging of cholesterol use is possible with the I scintiscanning/SPECT agent NP-59. This agent provided a noninvasive measure of adrenal function and steroid…”
Get full text

Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: An in vivo positron emission tomography study by Bohnen, Nicolaas I., Frey, Kirk A., Studenski, Stephanie, Kotagal, Vikas, Koeppe, Robert A., Constantine, Gregory M., Scott, Peter J.H., Albin, Roger L., Müller, Martijn L.T.M.

“…Cholinergic denervation has been associated with falls and slower gait speed and β‐amyloid deposition with greater severity of axial motor impairments in…”
Get full text

Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease by MÜLLER, Martijn L. T. M, ALBIN, Roger L, KOTAGAL, Vikas, KOEPPE, Robert A, SCOTT, Peter J. H, FREY, Kirk A, BOHNEN, Nicolaas I

“…The pathophysiology of postural instability in Parkinson's disease remains poorly understood. Normal postural function depends in part on the ability of the…”
Get full text

Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease by Shah, Neha, Frey, Kirk A., L.T.M Müller, Martijn, Petrou, Myria, Kotagal, Vikas, Koeppe, Robert A., Scott, Peter J.H., Albin, Roger L., Bohnen, Nicolaas I.

“…ABSTRACT Introduction Although most previous cognitive studies of β‐amyloidopathy in PD focused on cortical plaque deposition, recent postmortem studies point…”
Get full text

Striatal and Cortical [beta]-Amyloidopathy and Cognition in Parkinson's Disease by Shah, Neha, Frey, Kirk A, L.T.M Muller, Martijn, Petrou, Myria, Kotagal, Vikas, Koeppe, Robert A, Scott, Peter JH, Albin, Roger L, Bohnen, Nicolaas I

“…Introduction Although most previous cognitive studies of [beta]-amyloidopathy in PD focused on cortical plaque deposition, recent postmortem studies point to…”
Get full text

Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease by Bohnen, Nicolaas I, Kotagal, Vikas, Müller, Martijn L.T.M, Koeppe, Robert A, Scott, Peter J.H, Albin, Roger L, Frey, Kirk A, Petrou, Myria

“…Abstract Background There is increasing interest in interactions between metabolic syndromes and neurodegeneration. Diabetes mellitus (DM) contributes to…”
Get full text

A Comprehensive Assessment of 68Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients by Abghari-Gerst, Monica, Armstrong, Wesley R, Nguyen, Kathleen, Calais, Jeremie, Czernin, Johannes, Lin, David, Jariwala, Namasvi, Rodnick, Melissa, Hope, Thomas A, Hearn, Jason, Montgomery, Jeffrey S, Alva, Ajjai, Reichert, Zachery R, Spratt, Daniel E, Johnson, Timothy D, Scott, Peter JH, Piert, Morand

“…We prospectively investigated the performance of the prostate-specific membrane antigen (PSMA) ligand 68Ga-PSMA-11 for detecting prostate adenocarcinoma in…”
Get full text

Clinical markers for identifying cholinergic deficits in Parkinson's disease by Müller, Martijn L.T.M., Bohnen, Nicolaas I., Kotagal, Vikas, Scott, Peter J.H., Koeppe, Robert A., Frey, Kirk A., Albin, Roger L.

“…ABSTRACT Background Cholinergic projection systems degeneration is associated with dopamine nonresponsive features of Parkinson's disease (PD). Cholinergic…”
Get full text

Radiosynthesis and initial preclinical evaluation of [11C]AZD1283 as a potential P2Y12R PET radiotracer by Jackson, Isaac M., Buccino, Pablo J., Azevedo, E. Carmen, Carlson, Mackenzie L., Luo, Audrey S.Z., Deal, Emily M., Kalita, Mausam, Reyes, Samantha T., Shao, Xia, Beinat, Corinne, Nagy, Sydney C., Chaney, Aisling M., Anders, David A., Scott, Peter J.H., Smith, Mark, Shen, Bin, James, Michelle L.

“…Chronic neuroinflammation and microglial dysfunction are key features of many neurological diseases, including Alzheimer's Disease and multiple sclerosis…”
Get full text

Issues in preclinical radiopharmaceutical research: Significance, relevance and reproducibility by Kilbourn, Michael R., Scott, Peter J.H.

“…Kilbourn and Scott discuss the three critical factors that they believe should be applied to every preclinical study in radiopharmaceutical research. The…”
Get full text

Is logP truly dead? by Kilbourn, Michael R., Scott, Peter J.H.

“…More than 100 years ago, the importance of lipophilicity to the passive permeability of molecules through the blood brain barrier was recognized. In the…”
Get full text